Original Research

Treatment satisfaction among men with concurrent benign prostatic hyperplasia and erectile dysfunction treated with tadalafil or other phosphodiesterase type-5 inhibitor combinations

Lee LK, Goren A, Boytsov NN, Donatucci CF, McVary KT

Patient Preference and Adherence 2016, 10:1205-1215

Published Date: 12 July 2016